Talebi, A., Dehairs, J., Rambow, F., Rogiers, A., Nittner, D., Derua, R., . . . Swinnen, J. V. (2018). Sustained SREBP-1-dependent lipogenesis as a key mediator of resistance to BRAF-targeted therapy. Nature Portfolio.
Cita Chicago Style (17a ed.)Talebi, Ali, et al. Sustained SREBP-1-dependent Lipogenesis as a Key Mediator of Resistance to BRAF-targeted Therapy. Nature Portfolio, 2018.
Cita MLA (8a ed.)Talebi, Ali, et al. Sustained SREBP-1-dependent Lipogenesis as a Key Mediator of Resistance to BRAF-targeted Therapy. Nature Portfolio, 2018.
Precaución: Estas citas no son 100% exactas.